Compare CYTK & PAYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | PAYC |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.9B |
| IPO Year | 2004 | 2014 |
| Metric | CYTK | PAYC |
|---|---|---|
| Price | $59.89 | $126.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 15 |
| Target Price | $87.56 | ★ $170.71 |
| AVG Volume (30 Days) | 1.7M | ★ 2.2M |
| Earning Date | 05-25-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 8.08 |
| Revenue | $13,368,000.00 | ★ $433,047,000.00 |
| Revenue This Year | $9.79 | $8.79 |
| Revenue Next Year | $302.66 | $7.44 |
| P/E Ratio | ★ N/A | $16.12 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.31 | $104.90 |
| 52 Week High | $70.98 | $267.76 |
| Indicator | CYTK | PAYC |
|---|---|---|
| Relative Strength Index (RSI) | 40.30 | 44.60 |
| Support Level | $59.25 | $112.93 |
| Resistance Level | $65.93 | $159.30 |
| Average True Range (ATR) | 2.65 | 5.40 |
| MACD | -0.32 | 1.33 |
| Stochastic Oscillator | 3.98 | 55.26 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.